Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Hippocampal neurogenesis and neural circuit formation in a cuprizone-induced multiple sclerosis mouse model.

Zhang H, Kim Y, Jeoung Ro E, Ho C, Lee D, Trapp BD, Suh H.

J Neurosci. 2019 Nov 12. pii: 0866-19. doi: 10.1523/JNEUROSCI.0866-19.2019. [Epub ahead of print]

PMID:
31719166
2.

Oligodendrocyte Intrinsic miR-27a Controls Myelination and Remyelination.

Tripathi A, Volsko C, Garcia JP, Agirre E, Allan KC, Tesar PJ, Trapp BD, Castelo-Branco G, Sim FJ, Dutta R.

Cell Rep. 2019 Oct 22;29(4):904-919.e9. doi: 10.1016/j.celrep.2019.09.020.

3.

Resuscitation and Evacuation from Low Earth Orbit: A Systematic Review.

Nowadly CD, Trapp BD, Robinson SK, Richards JR.

Prehosp Disaster Med. 2019 Oct;34(5):521-531. doi: 10.1017/S1049023X19004734. Epub 2019 Aug 29.

PMID:
31462335
4.

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis.

Dutta R, Mahajan KR, Nakamura K, Ontaneda D, Chen J, Volsko C, Dudman J, Christie E, Dunham J, Fox RJ, Trapp BD.

J Vis Exp. 2019 Jul 19;(149). doi: 10.3791/59511.

PMID:
31380830
5.

Brain fibrinogen deposition plays a key role in MS pathophysiology - Yes.

Davalos D, Mahajan KR, Trapp BD.

Mult Scler. 2019 Oct;25(11):1434-1435. doi: 10.1177/1352458519852723. Epub 2019 Jul 18. No abstract available.

PMID:
31315512
6.

pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.

Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Healy L, Ho Jang J, Kang T Xu Y, Volsko C, Dutta R, Trapp BD, Perron H, Hartung HP, Küry P.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15216-15225. doi: 10.1073/pnas.1901283116. Epub 2019 Jun 18.

PMID:
31213545
7.

Identifying a new subtype of multiple sclerosis.

Trapp BD, Ontaneda D.

Neurodegener Dis Manag. 2018 Dec;8(6):367-369. doi: 10.2217/nmt-2018-0032. Epub 2018 Sep 14.

8.

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.

Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA.

Lancet Neurol. 2018 Oct;17(10):870-884. doi: 10.1016/S1474-4422(18)30245-X. Epub 2018 Aug 22.

9.

Lateral cerebellar nucleus stimulation promotes motor recovery and suppresses neuroinflammation in a fluid percussion injury rodent model.

Chan HH, Wathen CA, Mathews ND, Hogue O, Modic JP, Kundalia R, Wyant C, Park HJ, Najm IM, Trapp BD, Machado AG, Baker KB.

Brain Stimul. 2018 Nov - Dec;11(6):1356-1367. doi: 10.1016/j.brs.2018.07.051. Epub 2018 Jul 25.

PMID:
30061053
10.

Much, if not all, of the cortical damage in MS can be attributed to the microglial cell - No.

Dutta R, Trapp BD.

Mult Scler. 2018 Jun;24(7):897-899. doi: 10.1177/1352458517743094. Epub 2018 May 14. No abstract available.

11.

The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.

Koenig KA, Rao SM, Lowe MJ, Lin J, Sakaie KE, Stone L, Bermel RA, Trapp BD, Phillips MD.

Mult Scler. 2019 Apr;25(4):574-584. doi: 10.1177/1352458518760716. Epub 2018 Mar 7.

PMID:
29512427
12.

A histone deacetylase 3-dependent pathway delimits peripheral myelin growth and functional regeneration.

He X, Zhang L, Queme LF, Liu X, Lu A, Waclaw RR, Dong X, Zhou W, Kidd G, Yoon SO, Buonanno A, Rubin JB, Xin M, Nave KA, Trapp BD, Jankowski MP, Lu QR.

Nat Med. 2018 Mar;24(3):338-351. doi: 10.1038/nm.4483. Epub 2018 Feb 12.

13.

MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study.

Chen J, Kostenko V, Pioro EP, Trapp BD.

Radiology. 2018 Jun;287(3):955-964. doi: 10.1148/radiol.2018162967. Epub 2018 Jan 23.

14.

Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.

Jawaid S, Kidd GJ, Wang J, Swetlik C, Dutta R, Trapp BD.

Glia. 2018 Apr;66(4):789-800. doi: 10.1002/glia.23284. Epub 2017 Dec 23.

15.

T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.

Nakamura K, Chen JT, Ontaneda D, Fox RJ, Trapp BD.

Ann Neurol. 2017 Oct;82(4):635-639. doi: 10.1002/ana.25019. Epub 2017 Sep 21.

PMID:
28833377
16.

DNA methylation in demyelinated multiple sclerosis hippocampus.

Chomyk AM, Volsko C, Tripathi A, Deckard SA, Trapp BD, Fox RJ, Dutta R.

Sci Rep. 2017 Aug 18;7(1):8696. doi: 10.1038/s41598-017-08623-5.

17.

Integrin-Kindlin3 requirements for microglial motility in vivo are distinct from those for macrophages.

Meller J, Chen Z, Dudiki T, Cull RM, Murtazina R, Bal SK, Pluskota E, Stefl S, Plow EF, Trapp BD, Byzova TV.

JCI Insight. 2017 Jun 2;2(11). pii: 93002. doi: 10.1172/jci.insight.93002. eCollection 2017 Jun 2.

18.

BACE1 regulates the proliferation and cellular functions of Schwann cells.

Hu X, Hou H, Bastian C, He W, Qiu S, Ge Y, Yin X, Kidd GJ, Brunet S, Trapp BD, Baltan S, Yan R.

Glia. 2017 May;65(5):712-726. doi: 10.1002/glia.23122. Epub 2017 Feb 13.

19.

GlcNAc6ST-1 regulates sulfation of N-glycans and myelination in the peripheral nervous system.

Yoshimura T, Hayashi A, Handa-Narumi M, Yagi H, Ohno N, Koike T, Yamaguchi Y, Uchimura K, Kadomatsu K, Sedzik J, Kitamura K, Kato K, Trapp BD, Baba H, Ikenaka K.

Sci Rep. 2017 Feb 10;7:42257. doi: 10.1038/srep42257.

20.

Discovery of 1,2,3-Triazole Derivatives for Multimodality PET/CT/Cryoimaging of Myelination in the Central Nervous System.

Wu C, Eck B, Zhang S, Zhu J, Tiwari AD, Zhang Y, Zhu Y, Zhang J, Wang B, Wang X, Wang X, You J, Wang J, Guan Y, Liu X, Yu X, Trapp BD, Miller R, Silver J, Wilson D, Wang Y.

J Med Chem. 2017 Feb 9;60(3):987-999. doi: 10.1021/acs.jmedchem.6b01328. Epub 2017 Jan 20.

PMID:
28107629
21.

Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling.

Yin X, Kidd GJ, Ohno N, Perkins GA, Ellisman MH, Bastian C, Brunet S, Baltan S, Trapp BD.

J Cell Biol. 2016 Nov 21;215(4):531-542.

22.

Is Axonal Degeneration a Key Early Event in Parkinson's Disease?

Kurowska Z, Kordower JH, Stoessl AJ, Burke RE, Brundin P, Yue Z, Brady ST, Milbrandt J, Trapp BD, Sherer TB, Medicetty S.

J Parkinsons Dis. 2016 Oct 19;6(4):703-707. Review.

PMID:
27497486
23.

Relapses in multiple sclerosis: Relationship to disability.

Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E.

Mult Scler Relat Disord. 2016 Mar;6:10-20. doi: 10.1016/j.msard.2015.09.002. Epub 2015 Sep 8. Review.

PMID:
27063617
24.

Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio.

Morris JK, Chomyk A, Song P, Parker N, Deckard S, Trapp BD, Pimplikar SW, Dutta R.

Invert Neurosci. 2015 Sep;15(3):4. doi: 10.1007/s10158-015-0180-1. Epub 2015 Jul 10.

PMID:
26159098
25.

Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination.

Puntambekar SS, Hinton DR, Yin X, Savarin C, Bergmann CC, Trapp BD, Stohlman SA.

Glia. 2015 Nov;63(11):2106-2120. doi: 10.1002/glia.22880. Epub 2015 Jun 30.

26.

The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.

Koenig KA, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel RA, Beall EB, Rao SM, Trapp BD, Phillips MD.

Mult Scler. 2015 Dec;21(14):1794-801. doi: 10.1177/1352458515576983. Epub 2015 Jun 23.

27.

Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.

Savarin C, Hinton DR, Valentin-Torres A, Chen Z, Trapp BD, Bergmann CC, Stohlman SA.

J Neuroinflammation. 2015 Apr 22;12:79. doi: 10.1186/s12974-015-0293-9.

28.

Pathological mechanisms in progressive multiple sclerosis.

Mahad DH, Trapp BD, Lassmann H.

Lancet Neurol. 2015 Feb;14(2):183-93. doi: 10.1016/S1474-4422(14)70256-X. Review.

PMID:
25772897
29.

Cuprizone does not induce CNS demyelination in nonhuman primates.

Chen Z, Chen JT, Johnson M, Gossman ZC, Hendrickson M, Sakaie K, Martinez-Rubio C, Gale JT, Trapp BD.

Ann Clin Transl Neurol. 2015 Feb;2(2):208-13. doi: 10.1002/acn3.159. Epub 2014 Dec 18.

30.

Microglia and neuroprotection.

Chen Z, Trapp BD.

J Neurochem. 2016 Jan;136 Suppl 1:10-7. doi: 10.1111/jnc.13062. Epub 2015 Mar 10. Review.

31.

Mitochondrial fission augments capsaicin-induced axonal degeneration.

Chiang H, Ohno N, Hsieh YL, Mahad DJ, Kikuchi S, Komuro H, Hsieh ST, Trapp BD.

Acta Neuropathol. 2015 Jan;129(1):81-96. doi: 10.1007/s00401-014-1354-3. Epub 2014 Oct 17.

32.

Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.

Prins M, Dutta R, Baselmans B, Brevé JJ, Bol JG, Deckard SA, van der Valk P, Amor S, Trapp BD, de Vries HE, Drukarch B, van Dam AM.

Acta Neuropathol Commun. 2014 Aug 23;2:98. doi: 10.1186/s40478-014-0098-6.

33.

Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.

Yin X, Kiryu-Seo S, Kidd GJ, Feltri ML, Wrabetz L, Trapp BD.

Glia. 2015 Jan;63(1):66-77. doi: 10.1002/glia.22733. Epub 2014 Jul 28.

34.

Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain.

Chen Z, Jalabi W, Hu W, Park HJ, Gale JT, Kidd GJ, Bernatowicz R, Gossman ZC, Chen JT, Dutta R, Trapp BD.

Nat Commun. 2014 Jul 22;5:4486. doi: 10.1038/ncomms5486.

35.

Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.

Ohno N, Chiang H, Mahad DJ, Kidd GJ, Liu L, Ransohoff RM, Sheng ZH, Komuro H, Trapp BD.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9953-8. doi: 10.1073/pnas.1401155111. Epub 2014 Jun 23.

36.

Relapsing and progressive forms of multiple sclerosis: insights from pathology.

Dutta R, Trapp BD.

Curr Opin Neurol. 2014 Jun;27(3):271-8. doi: 10.1097/WCO.0000000000000094. Review.

37.

Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis.

Koenig KA, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel RA, Beall EB, Rao SM, Trapp BD, Phillips MD.

Magn Reson Imaging. 2014 May;32(4):354-8. doi: 10.1016/j.mri.2013.12.012. Epub 2013 Dec 30.

38.

Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.

Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, Trapp BD, Haroutunian V, Zhu J, Donovan MJ, Sharp AJ, Casaccia P.

Nat Neurosci. 2014 Jan;17(1):121-30. doi: 10.1038/nn.3588. Epub 2013 Nov 24.

39.

Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.

Kang Z, Wang C, Zepp J, Wu L, Sun K, Zhao J, Chandrasekharan U, DiCorleto PE, Trapp BD, Ransohoff RM, Li X.

Nat Neurosci. 2013 Oct;16(10):1401-8. doi: 10.1038/nn.3505. Epub 2013 Sep 1.

40.

Biology of Schwann cells.

Kidd GJ, Ohno N, Trapp BD.

Handb Clin Neurol. 2013;115:55-79. doi: 10.1016/B978-0-444-52902-2.00005-9. Review.

PMID:
23931775
41.

Sex differences in resting-state functional connectivity in multiple sclerosis.

Koenig KA, Lowe MJ, Lin J, Sakaie KE, Stone L, Bermel RA, Beall EB, Rao SM, Trapp BD, Phillips MD.

AJNR Am J Neuroradiol. 2013 Dec;34(12):2304-11. doi: 10.3174/ajnr.A3630. Epub 2013 Jun 27.

42.

Activated microglia enhance neurogenesis via trypsinogen secretion.

Nikolakopoulou AM, Dutta R, Chen Z, Miller RH, Trapp BD.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8714-9. doi: 10.1073/pnas.1218856110. Epub 2013 May 6.

43.

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.

Dutta R, Chomyk AM, Chang A, Ribaudo MV, Deckard SA, Doud MK, Edberg DD, Bai B, Li M, Baranzini SE, Fox RJ, Staugaitis SM, Macklin WB, Trapp BD.

Ann Neurol. 2013 May;73(5):637-45. doi: 10.1002/ana.23860. Epub 2013 Apr 17.

44.

High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.

Koenig KA, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel RA, Beall EB, Rao SM, Trapp BD, Phillips MD.

Magn Reson Imaging. 2013 Jun;31(5):695-9. doi: 10.1016/j.mri.2012.10.030. Epub 2013 Jan 5.

45.

Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".

Trapp BD.

J Peripher Nerv Syst. 2012 Dec;17 Suppl 3:20-3. doi: 10.1111/j.1529-8027.2012.00426.x. Review.

PMID:
23279427
46.

Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.

Staugaitis SM, Chang A, Trapp BD.

Acta Neurol Scand Suppl. 2012;(195):97-102. doi: 10.1111/ane.12041. Review.

PMID:
23278664
47.

Clinically feasible MTR is sensitive to cortical demyelination in MS.

Chen JT, Easley K, Schneider C, Nakamura K, Kidd GJ, Chang A, Staugaitis SM, Fox RJ, Fisher E, Arnold DL, Trapp BD.

Neurology. 2013 Jan 15;80(3):246-52. doi: 10.1212/WNL.0b013e31827deb99. Epub 2012 Dec 26.

48.

Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD.

Ann Neurol. 2012 Dec;72(6):918-26. doi: 10.1002/ana.23693. Epub 2012 Oct 17.

49.

Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.

Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohlman SA, Trapp BD.

J Neurosci. 2012 Aug 22;32(34):11706-15. doi: 10.1523/JNEUROSCI.0730-12.2012.

50.

Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Campbell GR, Kraytsberg Y, Krishnan KJ, Ohno N, Ziabreva I, Reeve A, Trapp BD, Newcombe J, Reynolds R, Lassmann H, Khrapko K, Turnbull DM, Mahad DJ.

Acta Neuropathol. 2012 Aug;124(2):209-20. doi: 10.1007/s00401-012-1001-9. Epub 2012 Jun 12.

Supplemental Content

Loading ...
Support Center